European active surveillance study of women taking HRT (EURAS-HRT): study protocol [NCT00214903]
<p>Abstract</p> <p>Background</p> <p>The post marketing safety surveillance program for a drug containing a new chemical entity should assess both, the safety outcomes that relate specifically to the targeted population, as well as those that could potentially be relate...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2006-01-01
|
| Series: | BMC Women's Health |
| Online Access: | http://www.biomedcentral.com/1472-6874/6/1 |